Could rice formula be a safe alternative for kids allergic to Cow's milk?

NCT ID NCT07197814

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a new formula made from hydrolyzed rice proteins is safe for infants and young children (1–36 months) with IgE-mediated cow's milk allergy. In a double-blind test, children will receive either the rice formula or a placebo, then be monitored for allergic reactions. If no reactions occur, they will drink the rice formula exclusively for 7 days at home. The goal is to see if this formula can be labeled hypoallergenic, offering a new option for families managing cow's milk allergy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

hydrolyzed rice protein formula

What this could lead to

If successful, this could provide a safe, hypoallergenic formula option for children with cow's milk allergy, reducing reliance on more expensive or less palatable alternatives.

What could go wrong

This is a small early-stage trial (29 children) with no control for long-term safety. Some children may still react to the rice formula, and results may not apply to all allergic children.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IGE-MEDIATED COW MILK ALLERGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

food allergy Milk Hypersensitivity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Federico II, University of Naples, Department of Translational Medical Science

    RECRUITING

    Naples, Italy

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact